SyntekaBio Grants Stock Options for 392,000 Shares to Directors, Employees

SyntekaBio granted stock options covering 392,000 common shares on Oct. 16, 2026, to 33 directors and employees. The award represents 1.62% of issued shares, bringing total outstanding stock options to 1,132,500 shares. One director received options over 300,000 shares; another received 5,000, with employees allocated the remaining 87,000. The exercise price is KRW 1,192, with exercise permitted from Oct. 16, 2028, through Oct. 15, 2031. Recipients must complete at least two years of service from the grant date and remain employed when exercising their options. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SyntekaBio Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261016000498), on October 16, 2026, and is solely responsible for the information contained therein. (C)